Arlita Pang

528 total citations
7 papers, 426 citations indexed

About

Arlita Pang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Periodontics. According to data from OpenAlex, Arlita Pang has authored 7 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Periodontics. Recurrent topics in Arlita Pang's work include Lung Cancer Treatments and Mutations (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Arlita Pang is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Arlita Pang collaborates with scholars based in United States. Arlita Pang's co-authors include Scott M. Lippman, Steven E. Benner, William K. Murphy, Bonnie S. Glisson, Frank V. Fossella, Mark Calayag, Dongjun Shin, Martin Chasen, Herbert A. Fritsche and John Lee and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Arlita Pang

7 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arlita Pang United States	7	236	196	134	60	59	7	426
D. D. Liu United States	6	186 0.8×	172 0.9×	109 0.8×	42 0.7×	28 0.5×	7	333
Misset Jl France	10	157 0.7×	63 0.3×	84 0.6×	35 0.6×	24 0.4×	43	325
N Tradati Italy	12	121 0.5×	50 0.3×	107 0.8×	37 0.6×	30 0.5×	20	480
Rossella Di Franco Italy	11	107 0.5×	185 0.9×	138 1.0×	21 0.3×	13 0.2×	32	481
Eriko Nakano Japan	12	270 1.1×	105 0.5×	133 1.0×	33 0.6×	13 0.2×	44	511
Mileka Gilbert United States	6	192 0.8×	96 0.5×	47 0.4×	9 0.1×	38 0.6×	13	416
E Okajima Japan	11	70 0.3×	101 0.5×	128 1.0×	32 0.5×	17 0.3×	52	417
Harinder S. Garewal United States	9	161 0.7×	167 0.9×	140 1.0×	24 0.4×	8 0.1×	14	617
Woo Gyeong Kim South Korea	11	134 0.6×	84 0.4×	68 0.5×	13 0.2×	6 0.1×	36	330
Yoshimi Sugama Japan	12	69 0.3×	55 0.3×	78 0.6×	33 0.6×	16 0.3×	20	345

Countries citing papers authored by Arlita Pang

Since Specialization

Citations

This map shows the geographic impact of Arlita Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlita Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlita Pang more than expected).

Fields of papers citing papers by Arlita Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlita Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlita Pang. The network helps show where Arlita Pang may publish in the future.

Co-authorship network of co-authors of Arlita Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Arlita Pang. A scholar is included among the top collaborators of Arlita Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlita Pang. Arlita Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hays, Granvil L., Scott M. Lippman, Ronald S. Brown, et al.. (1995). Co-carcinogenesis and field cancerization: oral lesions offer first signs. The Journal of the American Dental Association. 126(1). 47–51. 10 indexed citations

2.

Lee, John, Scott M. Lippman, Steven E. Benner, et al.. (1994). Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.. Journal of Clinical Oncology. 12(5). 937–945. 159 indexed citations

3.

Fossella, Frank V., William K. Murphy, Scott M. Lippman, et al.. (1994). Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.. Journal of Clinical Oncology. 12(6). 1238–1244. 197 indexed citations

4.

Lee, J. S., H I Libshitz, Frank V. Fossella, et al.. (1992). Improved Therapeutic Index by Leucovorin of Edatrexate, Cyclophosphamide, and Cisplatin Regimen for Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 84(13). 1039–1040. 12 indexed citations

5.

Ellerbroek, Nancy A., Waun Ki Hong, Jack A. Roth, et al.. (1991). Resectability of Small-Cell Lung Cancer Following Induction Chemotherapy in Patients with Limited Disease (Stage II-IIIb). American Journal of Clinical Oncology. 14(5). 427–432. 21 indexed citations

6.

Lee, Jin S., Herman I. Libshitz, Frank V. Fossella, et al.. (1991). Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer. Cancer. 68(5). 959–964. 10 indexed citations

7.

Lee, Jin S., William K. Murphy, Mihran Shirinian, Arlita Pang, & Waun Ki Hong. (1991). Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy. Cancer Chemotherapy and Pharmacology. 28(3). 199–204. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact